CorVel_Primary-Full Color.png
CorVel Announces New Integrations for Managed Care Services Enabling Partners to Increase Connectivity and Create a Seamless Workflow Experience
April 23, 2024 07:08 ET | CorVel Corp.
CorVel (NASDAQ: CRVL) unveils AI-driven managed care solutions, offering seamless integration and enhanced insights for partners, improving patient care.
Manhattan_Bridge_Capital_sg.jpg
Manhattan Bridge Capital, Inc. Reports First Quarter Results for 2024
April 23, 2024 07:05 ET | Manhattan Bridge Capital, Inc.
GREAT NECK, N.Y., April 23, 2024 (GLOBE NEWSWIRE) -- Manhattan Bridge Capital, Inc. (Nasdaq: LOAN) announced today that its net income for the three months ended March 31, 2024...
lantronix_logo_with-r-ball.png
Lantronix to Participate in the 21st Annual Craig-Hallum Institutional Investor Conference on May 29, 2024
April 23, 2024 07:02 ET | Lantronix, Inc.
Lantronix to Participate in the 21st Annual Craig-Hallum Institutional Investor Conference on May 29, 2024
Apellis logo.jpg
Apellis Pharmaceuticals to Host Conference Call on May 7, 2024, to Discuss First Quarter 2024 Financial Results
April 23, 2024 07:00 ET | Apellis Pharmaceuticals, Inc.
WALTHAM, Mass., April 23, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a conference call and webcast to discuss its first quarter...
Omega_logo1.png
Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting
April 23, 2024 07:00 ET | Omega Therapeutics
CAMBRIDGE, Mass., April 23, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of...
OCHLogo.png
Option Care Health Announces Financial Results for the First Quarter Ended March 31, 2024
April 23, 2024 07:00 ET | Option Care Health, Inc.
BANNOCKBURN, Ill., April 23, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate...
tiziana-logo.png
Tiziana Life Sciences Announces FDA Allowance for Additional Twenty Patients to be Enrolled in the Intranasal Foralumab Multiple Sclerosis Expanded Access Program
April 23, 2024 07:00 ET | Tiziana Life Sciences Ltd.
NEW YORK, April 23, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
Picture1.png
Autolus Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
April 23, 2024 07:00 ET | Autolus Therapeutics plc
Autolus Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
SKYE Logo.png
Skye Bioscience to Present at Upcoming Investment Conferences
April 23, 2024 07:00 ET | Skye Bioscience, Inc.
SAN DIEGO, April 23, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on the discovery, development and commercialization of...